SFX by Ex Libris Inc.

Title:	Biomedicine. A view from the top--prion diseases from 10,000 feet
Source:	Science [0036-8075] Priola, S A yr:2003

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hegde, R S S. "A transmembrane form of the prion protein in neurodegenerative disease." Science 279.5352 (1998): 827-834.
description	2.	Hooper, Jo M. "Lipid rafts: Linking Alzheimer's amyloid-β production, aggregation, and toxicity at neuronal membranes." International Journal of Alzheimer's Disease 2011 (2011): 603052-603052.
description	3.	Hegde, R S S. "Transmissible and genetic prion diseases share a common pathway of neurodegeneration." Nature 402.6763 (2000): 822-6.
description	4.	PAN, K. "CONVERSION OF ALPHA-HELICES INTO BETA-SHEETS FEATURES IN THE FORMATION OF THE SCRAPIE PRION PROTEINS." Proceedings of the National Academy of Sciences of the United States of America 90.23 (1993): 10962-10966.
description	5.	Prusiner, S B B. "Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein." Cell 83.1 (1995): 79-90.
description	6.	Nelson, D. "Structure of the cross-β spine of amyloid-like fibrils." Nature 435.7043 (2005): 773-778.
description	7.	Brown, Hans R. "Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity." Experimental Neurology 146.1 (1997): 104-112.
description	8.	Aumaitre, E. "On the measurement of the surface pressure in Langmuir films with finite shear elasticity." Soft matter 7.6 (2011): 2530-2537.
description	9.	Robinson, P. "Phospholipid Composition of Membranes Directs Prions Down Alternative Aggregation Pathways." Biophysical Journal 98.8 (2010): 1520-1528.
description	10.	Gobbi, M. "Lipid-based nanoparticles with high binding affinity for amyloid-β1-42 peptide." Biomaterials 31.25 (2010): 6519-6529.
description	11.	Oakley, H. "Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation." The journal of neuroscience 26.40 (2006): 10129-10140.
description	12.	Prusiner, S B B. "Molecular biology of prion diseases." Science 252.5012: 1515-1522.
description	13.	Sawaya, Michael R. "Atomic structures of amyloid cross-beta spines reveal varied steric zippers." Nature 447.7143 (2007): 453-457.
description	14.	TELLING, G. "TRANSMISSION OF CREUTZFELDT-JAKOB-DISEASE FROM HUMANS TO TRANSGENIC MICE EXPRESSING CHIMERIC HUMAN-MOUSE PRION PROTEIN." Proceedings of the National Academy of Sciences of the United States of America 91.21 (1994): 9936-9940.
description	15.	BUELER, H. "MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE." Cell 73.7 (1993): 1339-1347.
description	16.	Redecke, L. "Structural characterization of beta-sheeted oligomers formed on the pathway of oxidative prion protein aggregation in vitro." Journal of structural biology 157.2 (2007): 308-320.
description	17.	Collinge, J. "Prion diseases of humans and animals: their causes and molecular basis." Annual review of neuroscience 24.1: 519-550.
description	18.	Ohno, Masuo, J. "Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1." The European journal of neuroscience 23.1 (2006): 251-260.
description	19.	Ohno, M. "BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice." Neurobiology of disease 26.1 (2007): 134-45.
description	20.	Wulf, M. "The biological function of the cellular prion protein: an update." BMC biology. 15.1: 34-34.